Clay Matthews Applauds Approval of Eteplirsen for Duchenne Muscular Dystrophy

Clay Matthews

Clay Matthews from the Green Bay Packers is proud to support CureDuchenne in their mission to find a cure for Duchenne muscular dystrophy. The FDA granted accelerated approval to Sarepta for the first drug for Duchenne muscular dystrophy. CureDuchenne provided early funding to Sarepta that helped the company move into human clinical trials. We need to continue to advance treatments until there is a cure for all those with Duchenne. For more information go to

Video provided courtesy of CureDuchenne.
Printer Printing...